Company intelligence / Profile preview

Troon

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Troon Therapeutics is an early-stage biotechnology company focused on developing next-generation antibody-based therapies for oncology and immunology. Launched by Atlas Venture, the company leverages a proprietary platform to engineer antibodies with enhanced specificity and therapeutic potential. While currently in the pre-clinical stage, Troon aims to address significant unmet needs in complex disease areas through its innovative biologics pipeline. The company is part of the vibrant Cambridge biotech ecosystem and is led by experienced industry veterans and venture partners.

Therapeutic areas: OncologyImmunology
Modalities: AntibodyMonoclonal antibodyBispecific monoclonal antibody
Industry: Biotech

Beyond the preview

Go deeper on Troon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Troon.

Explore the full profile